Abstract
As a phytomedicine, Kava (or “Kava Kava”) is receiving considerable worldwide interest in its use as a treatment for anxiety, tension, agitation, and/or insomnia. This phytomedicine is produced from an extract of the root and rhizome of Piper methysticum. Although the term Kava actually refers to a Polynesian term for the intoxicating beverage produced from this tropical shrub, this word is now typically used in Western cultures as the common name for the plant as well.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bhat, S. R., Chandel, P. S., and Malik, S. K. (1995). Plant regeneration from various explants of cultured Piper species. Plant Cell Reports 14:398–402.
Bhojwani, S. S., and Razdan, M. K. (1996). Plant Tissue Culture: Theory And Practice, A Revised Edition. Elsevier, Amsterdam.
Borche, W., and Blount, B. K. (1933). Undersuchungen Ober die bestandteile der Kawawurzel XIII. Mitteil, Ober einige neue stoffe aus technischem. Chemische Berichte 66:803–806.
Brevoort, P. (1998). The booming U.S. botanical market. A new overview. HerbalGram 44:33–46.
Briskin, D., Kobayashi, H., Metha, A., Gawienowski, M., Ainsworth, L., and Smith, M. A. L. (2001). Production of kavapyrones by Kava (Piper methysticum) tissue cultures. Plant Cell Reports 20:556–561.
Bruneton, J. (1995). Pharmacognosy, Phytochemistry, Medicinal Plants. Lavisior Ltd., Paris.
Capasso, A., and Calignano, A. (1988). Synergism between the sedative action of kava extract and D,L-kawain. Acta Therapeutica 14:249–256.
Center for Food Safety and Applied Nutrition. U.S. Food and Drug Administration. (March 25, 2002). Kava-containing dietary supplements may be associated with liver injury. Available from: http://www.cfsan.fda.gov/~dms/addskava.html
Davies, L. P., Drew, C. A., Duffield, P., Johnston, G. A. R., and Jamieson, D. D. (1992). Kavapyrones and resin: Studies on GABAA, GABAB, and benzodiazepine binding sites in rodent brain. Pharmacology and Toxicology 71:120–126.
Denham, A., McIntyre, M., and Whitehouse, J. (2002). Kava—the unfolding story: Report on a work-in-progress. The Journal of Alternative and Complementary Medicine 8:237–263.
Dragull, K., Yoshida, Y. A., and Tang, C.-S. (2003). Piperidine alkaloids from Piper methysticum. Phytochemistry 63:193–198.
Fitchet, M. (1990). Tissue culture propagation of black pepper (Piper nigrum L.). Acta Horticultura 275:285–291.
Gleitz, J., Beile, A., and Peters, T. (1996). The action of kavain, a kavapyrone prepared from the psychotropic remedy Piper methysticum, on presynaptic neurotransmission. European Neuropsychopharmacology 6:S26-S27.
Gracza, L., and Ruff, P. (1980). Einfache methode zur trennung and quantitativen bestimmung von kawa-laktonen durch hochleistungs-fliissigkeits-chromatographie. Journal of Chromatograhy 93:486–490.
He, X.-G., Longze, L., and Lian, L.-Z. (1997). Electrospray high performance liquid chromatography2013mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract. Planta Medica 63:70–74.
Johnson, B. M., Qiu, S.-X., Zhang, S., Zhang, F., Burdette, J. E., Yu, L., Bolton, J. D., and van Breemen, R. B. (2003). Identification of novel electrophilic metabolites of Piper methysticum Forst. (Kava). Chemical Research in Toxicology 16:733–740.
Jussofie, A., Schmiz, A., and Hiemke, C. (1994). Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology 116:469–474.
Klohs, M. W., Keller, F., Williams, R. E., Toekes, M. I., and Cronheim, E. G. (1959). A chemical and pharmacological investigation of Piper methysticum Forst. Journal of Medicinal and Pharmaceutical Chemistry 1:95–99.
Kobayashi, H., Gawienowski, M. C., Lila, M. A., and Briskin, D. P. (in press). Kavapyrone production during tissue culture and regeneration of Kava (Piper methysticum). Phytochemistry.
Lebot, V., and Cabalion, P. (1988). Kavas of Vanuatu. Cultivars of Piper methysticum. Technical Paper No. 195, South Pacific Commission, Noumea.
Lebot, V., and Levesque, J. (1989). The origin and distribution of kava (Piper methysticum Forst. f., Piperaceae): A phytochemical approach. Allertonia 5:223–280.
Lebot, V., and Levesque, J. (1996). Genetic control of kavalactone chemotypes in Piper methysticum cultivars. Phytochemistry 43:397–403.
Lebot, V., Aradhya, M. K., and Manshardt, R. M. (1991). Geographical survey of genetic variation in Kava (Piper methysticum Forst. f.) and P. wichmannii. Pacific Science 45:169–185.
Lebot, V., Johnson, E., Zheng, Q.-Y., McKern, D., and McKenna, D. J. (1999). Morphological, phytochemical and genetic variation in Hawaiian cultivars of awa (Kava, Piper methysticum, Piperaceae). Economic Botany 53:407–418.
Lehmann, E., Kinzler, E., and Friedemann, J. (1996). Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin. A double-blind placebocontrolled study of four weeks treatment. Phytomedicine 3:113–119.
Murashige, T., and Skoog, F. (1962). A revised medium for rapid growth and bioassays with tobacco tissue cultures. Plant Physiology 15:473–497.
Philip, V. J., Dominic, J., Triggs, G. S., and Dickinson, N. M. (1992). Micropropagation of black pepper (Piper nigrum Linn.) through shoot tip cultures. Plant Cell Reports 12:41–44.
Roja, G., and Rao, P. S. (2000). Anticancer compounds from tissue cultures of medicinal plants. Journal of Herb, Spice, and Medicinal Plants 7:71–102.
Schelosky, L., Raffauf, C., Jendroska, K., and Poewe, W. (1995). Kava and dopamine antagonism. Journal of Neurology 58:639–640.
Schmitz, D., Zhang, C. L., Chatterjee, S. S., and Heinemann, U. (1995). Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices. Archives of Pharmacology 351:348–355.
Schroder, J. (1997). A family of plant-specific polyketide synthases: Facts and predictions. Trends in Plant Science 2:373–378.
Schulz, V., Hansel, R., and Tyler, V. E. (1998). Rational Phytotherapy. Springer-Verlag, Berlin.
Sengupta, S., and Ray, A. B. (1987). The chemistry of Piper species: A review. Fitoterapia 58:147–166.
Shao, Y., He, K., Zheng, B. L., and Zheng, Q. Y. (1998). Reversed-phase high-performance liquid chromatographic method for quantitative analysis of the six major kavalactones in Piper methysticum. Journal of Chromatography 825:1–8.
Singh, Y. N. (1992). Kava. An overview. Journal of Ethnopharmacology 37:13–45.
Singh, Y. N., and Blumenthal, M. (1997). Kava: An overview. HerbalGram 39:33–55.
Smith, R. M., Thakrar, H., Arowolo, T. A., and Shafi, A. A. (1984). High performance liquid chromatography of kava lactones from Piper methysticum. Journal of Chromatography 283:303–308.
Taylor, M., and Taufa, L. (1998). Decontamination of kava (Piper methysticum) for in vitro propagation. Acta Hort. 461:267–274.
Verpoorte, R., van der Heijden, R., ten Hoopen, H. J. G., and Memlink, J. (1998). Metabolite engineering for the improvement of plant secondary metabolite production. Plant Tissue Culture and Biotechnology 4:3–20.
Volz, H. P., and Kieser, M. (1997). Kava-Kava extract WS 1490 versus placebo in anxiety disorders. A randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 30:1–5.
Walden, J., von Wegerer, J., Winter, U., and Berger, M. (1997). Actions of kavain and dihydromethysticin on ipsapirone-induced field potential changes in the hippocampus. Human Psychopharmacology 12:265–270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic/Plenum Publishers, New York
About this chapter
Cite this chapter
Briskin, D.P., Kobayashi, H., Lila, M.A., Gawienowski, M. (2004). Kava (Piper methysticum): Growth in Tissue Culture and In Vitro Production of Kavapyrones. In: Dyer, L.A., Palmer, A.D.N. (eds) Piper: A Model Genus for Studies of Phytochemistry, Ecology, and Evolution. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30599-8_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-30599-8_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1008-3
Online ISBN: 978-0-387-30599-8
eBook Packages: Springer Book Archive